9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer

NCT06592326 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: 9MW2821
DRUG: Toripalimab
DRUG: Gemcitabine
DRUG: Cisplatin/Carboplatin

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.